Surgical specimens of breast tissue containing carcinoma were received fresh in the laboratory 15 min after removal from the patient. After standard pathological assessment and sampling for routine histology and hormone receptor assay, and if sufficient tumour was available, multiple slices, on average measuring 1 cm2, were taken and placed in a variety of fixatives (Table I) . Cytosols were prepared from frozen tissue after homogenisation using a microdismembrator (Braun, Melsungen, Germany) according to the instructions in the Abbott enzyme immmunoassay kit (Abbott Laboratories, Maidenhead, Berkshire, UK). The protein concentration of the cytosol extracts was determined by a dye-binding assay (Bradford, 1976 ethanol (six changes), clearing in xylene (three changes) and paraffin wax impregnation (four changes), the entire process taking 11 h. The tissues were then embedded and sectioned for routine histology and immunohistochemistry. Subsequent to the fixation study tissue from 95 consecutive cases of infiltrating mammary carcinoma and 20 cases of pure in situ or predominantly in situ carcinoma with minimal invasion (<2 mm maximum diameter) was fixed in phenol formol saline for evaluation of the different staining patterns seen with the p53 antibody.
Summary
The availability of antibodies which recognise p53 protein in paraffin-embedded tissue has created the opportunity to use immunohistochemistry to study the expression of p53 in a wide variety of clinical material. In this paper we have investigated the relationship between the type of fixative and the pattern of p53 staining in mammary carcinoma. Optimal results were obtained from breast tissue fixed in phenol formol saline, methacarn or cold formol saline with positive staining for stabilised p53 protein occurring in 69/95 (73%) cases studied. Care must be taken in the interpretation of these results since positive staining for p53 protein is not always indicative of mutation of the p53 gene. Furthermore, a range of staining patterns is seen in mammary carcinomas, making interpretation difficult. Assessment of staining needs to be standardised in order that different studies can be compared. However, in breast carcinoma, p53 immunohistochemistry appears to give information relating to tumour grade and, independently, to prognosis.
It is now well recognised that abnormalities in the p53 gene play an important role in many human cancers (Levine et al., 1991) . Although wild-type p53 protein has a short half-life, many mutations stabilise the protein, thus making it amenable to detection by immunohistochemistry. Initially, it was thought that all immunohistochemically detected protein was mutant. It is becoming increasingly apparent, however, that this is not so. Increase in expression of the normal protein can occur in response to DNA damage (Kastan et al., 1991; Hall et al., 1993; Rasbridge et al., 1993) 
Materials and methods
Surgical specimens of breast tissue containing carcinoma were received fresh in the laboratory 15 min after removal from the patient. After standard pathological assessment and sampling for routine histology and hormone receptor assay, and if sufficient tumour was available, multiple slices, on average measuring 1 cm2, were taken and placed in a variety of fixatives (Table I) . Cytosols were prepared from frozen tissue after homogenisation using a microdismembrator (Braun, Melsungen, Germany) according to the instructions in the Abbott enzyme immmunoassay kit (Abbott Laboratories, Maidenhead, Berkshire, UK). The protein concentration of the cytosol extracts was determined by a dye-binding assay (Bradford, 1976 ethanol (six changes), clearing in xylene (three changes) and paraffin wax impregnation (four changes), the entire process taking 11 h. The tissues were then embedded and sectioned for routine histology and immunohistochemistry. Subsequent to the fixation study tissue from 95 consecutive cases of infiltrating mammary carcinoma and 20 cases of pure in situ or predominantly in situ carcinoma with minimal invasion (<2 mm maximum diameter) was fixed in phenol formol saline for evaluation of the different staining patterns seen with the p53 antibody.
Tumour typing and grading Infiltrating tumour types were classified according to a modification of the WHO (1982) system. Tumour grading was carried out on all infiltrating ductal carcinomas and tumours of special type. Infiltrating lobular carcinomas were not graded. The histological grading was based on the method of Bloom and Richardson as modified by Elston and Ellis (1991) . Cases of in situ ductal carcinoma were classified as comedo when composed of large pleomorphic cells, usually with areas of extensive necrosis, or non-comedo when composed of small or intermediate-sized cells with minimal or no necrosis, usually with a cribriform or micropapillary pattern (Bobrow et al., 1993) .
Immunohistochemistry
Sections of 3 ym were cut and floated onto glass slides coated with poly-L-lysine and allowed to dry overnight. Heat was not used to stick the tissue sections on to the glass as this can Table II .
Assessment of fixatives Sixteen tumours were of sufficient size to allow a number of 1-cm2 slices to be fixed in a variety of ways. Eight of these tumours (Table III) stained positively for p53 and the quality of the immunohistochemical staining was assessed in these. Assessment included the strength of fixatives which optimally preserved antigenicity. Very occasional nuclear staining was seen in apparently normal epithelial tissue immediately adjacent to some tumours. Otherwise, normal epithelial elements in tissue surrounding tumours were negative in all cases and in all fixatives.
Analysis of immunohistochemical staining patterns using optimum fixation This was analysed in the 95 infiltrating and 20 in situ mammary carcinomas which were fixed in phenol formol saline. Sixty-nine (73%) of the 95 infiltrating carcinomas showed nuclear staining with CM-1. In 25 (26%) of the tumours the reaction was strong (Figure la) or moderate (Figure lb) . Two cases showed focal cytoplasmic staining only. Tumours showing nuclear staining were analysed according to histological type and histological grade (Tables IV and  V) Five per cent of cases showed isolated, darkly positive nuclei scattered throughout an otherwise negative tumour (scattered staining) (Figure 1c ). This is a constant finding in several separate studies in our laboratory and appears to be a genuine pattern of p53 protein expression. In the analysis of grade these tumours were included with the moderate stainers. All negative tumours were excluded from the statistical analysis because lack of staining is not solely an indication of the presence of normal p53 protein but will also be seen when both p53 alleles have been lost, or if a particular mutation has resulted in an extremely rapid disappearance of the protein.
Ten of 18 cases of pure ductal carcinoma in situ (DCIS) and the two microinvasive DCIS cases showed positive staining (Table VI) . Strong or moderate staining was seen in 7 of 12 comedo-type DCIS, the remaining five cases being negative. Only one non-comedo DCIS showed strong staining; two stained weakly and five were negative. This finding is consistent with the association of strong staining in highgrade tumours.
ELISA
There was a highly significant correlation between the immunohistochemical staining pattern and the ELISA score for the amount of p53 protein (Table VII) . All eight of the strong (n = 7) or moderate (n = 1) stainers were positive by the ELISA. These tumours were all infiltrating ductal grade III carcinomas. The remaining ten carcinomas were negative by ELISA; five were also negative by immunohistochemistry and five showed weak or scattered positive staining (rank correlation coefficient r=0.871, P<0.0001).
Discussion
With the rapid development of a range of antibodies to the p53 protein which work in fixed tissue Vojtesek et al., 1992; Bartek et al., 1993) it is now possible to carry out large retrospective studies of the protein expression in a variety of human cancers. It is essential, therefore, that the effect of different types of fixation on antigen preservation is recognised and the results of staining evaluated in the light of this knowledge. This study has shown that some fixatives appear to preserve the antigenicity of the p53 protein better than others. This particularly applies to tumours showing only weak nuclear staining. Pearson's correlation coefficient r = 0.676, P <0.0001. Rank correlation coefficient r = 0.871, P <0.0001.
In our laboratory it is essential for diagnostic purposes to have a rapid method of fixation. In the past we have used formol saline or formol calcium, both for lih at 55°C, in order to speed up the fixation before the tissues are processed to paraffin wax. While these procedures gave satisfactory morphology for diagnostic purposes we have recently found that this rapid fixation caused a loss of antigenicity of some nuclear antigens and gave very poor-quality DNA for flow cytometry. The paper by Hopwood et al. (1989) describing a novel method of rapid fixation in phenol formol saline encouraged us to re-evaluate the fixatives used in our laboratory. We investigated the nine fixatives employed in this study for their suitability for use with a wide range of other antibodies as well as their suitability for use in a diagnostic laboratory with regard to speed of fixation and preservation of cell morphology (Cooper et al., 1992) . As a result we now use phenol formol saline as our routine fixative. It is good for the preservation of antigenicity for a wide range of antibodies, including those to p53. Tissue fixed in this way has good morphology and fixation is rapid and, in addition, gives excellent preservation of DNA for use in flow cytometry and in analyses using the polymerase chain reaction technique.
Heat was found to be particularly deleterious with regard to antigen preservation for p53 (Table III) (Cattoretti et al., 1988) , others only where staining is seen in more than 20% of cells (Isola et al., 1992) , and yet others insist on widespread staining before accepting positivity (Davidoff et al., 1991) . In some papers attention is also paid to the strength of staining. If, however, p53 immunohistochemistry is to be of value in studying the biology of breast cancer there is a need to reach a consensus about the best way to assess the degree of positive staining so that studies from different centres are comparable.
The range of staining patterns and the effects of different fixatives may reflect the variety of structural forms produced by different mutations in the p53 molecule. Bodner et al. (1992) concluded from work on cell lines that the pattern of protein expression in tumour cells detected by immunohistochemistry is dependent upon the type of mutation in the p53 tumour-suppressor gene. Bartek et al. (1990) consider that the strength of staining is related to the amount of p53 protein present, and our studies support this. The 18 cytosols measured by the ELISA in this study also formed part of a larger series in which the number of positive cells was counted and the depth of staining considered in order to calculate a staining index. The index showed a positive association with the amount of p53 protein measured by the ELISA.
In agreement with other studies we found a good correlation between staining and histological grade. Strong and moderate staining was only seen in grade II and III tumours and the majority were grade III. Interestingly, negative staining was more frequent in grade III tumours. A possible explanation for this is that many of these tumours have lost both alleles and, therefore, the ability to make any p53 protein. If this is so the detection of weak staining becomes more important as its presence excludes tumours which have lost both alleles. In cases of DCIS strong staining was also seen more frequently in the comedo pattern composed of high-grade pleomorphic cells. In contrast to low-grade infiltrating tumours, which all showed weak staining, five of the eight low-grade non-comedo DCIS were negative. This could be because p53 is normal in this pattern of DCIS or, as most of the lesions were small, perhaps because there were insufficient tumour cells available to demonstrate focal positive staining.
As pointed out by Wynford-Thomas (1992) , positive staining does not necessarily indicate the presence of a mutation in the p53 gene. In a recent paper Mazars et al. (1992) found mutations in only 18/95 (19%) breast carcinomas, which is considerably lower than the reported prevalence of positive immunohistochemical staining. The p53 protein may be stabilised by other means such as a normal response to DNA damage (Lane, 1992) or by binding to proteins such as MDM2 (Oliner et al., 1992) or GADD45 (Kastan et al., 1992) . The complexity of the present situation is well set out in the recent editorial by Yandell and Thor (1993) .
Studies evaluating the prognostic value of p53 immunohistochemical detection have generally shown an association with poor prognosis (Isola et al., 1992; Thor et al., 1992; Allred et al., 1993) . A recent study from our laboratory suggests that it is the proportion of tumour cells that stain positively that is important. Tumours in which the majority of cells stain for p53 protein have a poorer prognosis than tumours in which few cells stain and this correlation is independent of histological grade .
In conclusion, caution must be exercised in the evaluation of p53 protein expression detected by immunohistochemistry. The stability of the protein is affected by different fixation methods, and this particularly applies to weak staining. Negative staining does not necessarily mean that there is no abnormality in the p53 gene and, conversely, positive staining does not always indicate mutant protein. There is a need for the method of assessment of positive staining to be standardised. Despite these limitations, however, p53 appears to give information relating to tumour grade and independently to prognosis.
